Articles related to Pulmonology

The FDA’s approval of new COVID-19 vaccines targeting the KP.2 strain comes amidst concerns about waning immunity and evolving virus variants.

The CDC reports “very high” COVID-19 levels in 32 states, with two new Omicron variants accounting for more than half of all US cases.

Recent studies have identified a range of chemical compounds released by face masks, including microplastics, volatile organic compounds, and plasticizers, prompting a closer examination of potential cumulative exposure risks.

Neffy®, an FDA-approved intranasal epinephrine spray, demonstrates bioequivalence to injectable epinephrine for anaphylaxis treatment in patients weighing ≥30kg, potentially reducing barriers to rapid intervention.

The study found no evidence that any of 25 routine clinical laboratory values provide a reliable biomarker of prior infection, PASC, or specific PASC clusters.

A comprehensive analysis of more than 2 million hospitalizations across 115+ US VA medical centers has revealed that 57% of patients treated for pneumonia experienced discordances between their initial and discharge diagnoses.